TAIPEI (Taiwan News) — A study by Chang Gung Memorial Hospital has discovered that removing the amino acid asparagine from ...
Maze Therapeutics IPOs at $487M, targeting APOL1 Kidney Disease with MZE829 in Phase 2. Click here to read an analysis of MAZE stock now.
The loss of muscle mass and strength poses an increasingly significant challenge for an ageing society. Prof. Kristina Norman's team at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE ...
Department of Inorganic Spectroscopy, Max Planck Institute for Chemical Energy Conversion, Stiftstr. 34-36, Mülheim an der Ruhr D-45470, Germany ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback